4//SEC Filing
White Mark Andrew 4
Accession 0001140361-24-032761
CIK 0001281895other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:05 PM ET
Size
4.8 KB
Accession
0001140361-24-032761
Insider Transaction Report
Form 4
White Mark Andrew
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-07-08$20.39/sh−3,026$61,715→ 72,220 total
Footnotes (1)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. RSUs vest one-third (1/3) upon the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments over the following two years.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001973240
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 4:05 PM ET
- Size
- 4.8 KB